A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder.

PHASE3CompletedINTERVENTIONAL
Enrollment

696

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Major Depressive Disorder
Interventions
DRUG

TC-5214

Twice daily for 8 weeks.

DRUG

Placebo

Twice daily for 8 weeks.

Trial Locations (87)

Unknown

Research Site, Buenos Aires

Research Site, Mendoza

Research Site, Ciudad Autonoma Bs As, Cba

Research Site, Dublin

Research Site, Rio de Janeiro

Research Site, Novi Iskar

Research Site, Rousse

Research Site, Santiago

Research Site, Antofagasta

Research Site, Providencia Santiago

Research Site, Bello

Research Site, Bogota

Research Site, Pereira

Research Site, Santiago de Cali

Research Site, Rijeka

Research Site, Bully-les-Mines

Research Site, Caen

Research Site, Cherbourg

Research Site, Colmar

Research Site, Dole

Research Site, Douai

Research Site, Élancourt

Research Site, Montpellier

Research Site, Sartrouville

Research Site, Strasbourg

Research Site, Toulon

Research Site, Toulouse

Research Site, Tours

Research Site, Hüttenberg

Research Site, Bad Homburg

Research Site, Bielefeld

Research Site, Gelsenkirchen

Research Site, Schwerin

Research Site, Siegen

Research Site, Balassagyarmat

Research Site, Budapest

Research Site, Győr

Research Site, Bydgoszcz

Research Site, Bialystok

Research Site, Leszno

Research Site, Lublin

Research Site, Torun

Research Site, Arad

Research Site, Brasov

Research Site, Bucharest

Research Site, Cluj-Napoca

Research Site, Focşani

Research Site, Oradea

Research Site, Timișoara

Research Site, Arkhangelsk

Research Site, Chita

Research Site, Novosibirsk

Research Site, Petrozavodsk

Research Site, Saint Petersburg

Research Site, Tomsk

Research Site, Voronezh

Research Site, Yekaterinburg

Research Site, Kragujevac

Research Site, Niš

Research Site, Banská Štiavnica

Research Site, Bratislava

Research Site, Levice

Research Site, Prešov

Research Site, Rimavská Sobota

Research Site, Svidník

Research Site, Trenčín

Research Site, Bloemfontein

Research Site, Vereeniging

Research Site, Cape Town

Research Site, Centurion

Research Site, Durban

Research Site, George

Research Site, Paarl

Research Site, Port Elizabeth

Research Site, Alcalá de Henares

Research Site, Coslada

Research Site, Langreo

Research Site, Kharkiv

Research Site, Simferpool

Research Site, Vinnytsia

Research Site, Dnipropetrovsk

Research Site, Donetsk

Research Site, Kherson

Research Site, Kiev

Research Site, Lviv

Research Site, Poltava

Research Site, Ternopil

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Targacept Inc.

INDUSTRY

lead

AstraZeneca

INDUSTRY